7.3.1 In implementing regulations related to intellectual property rights, Government shall take advantage of all the safeguards within the TRIPS Agreement for the promotion of public health and ensuring access to pharmaceuticals.

7.3.2 Government shall not enact legislation and regulations more stringent than the TRIPS requirement.

7.3.3 The MOH shall actively collaborate with the Ministry of Trade and Industry, Attorney General's Department and other relevant agencies in the area of intellectual property rights in developing consistent legal framework that enhances access to essential drugs.

7.3.4 Parallel importation shall be permitted for pharmaceuticals when the protection of the health of the public is concerned.

7.3.5 The government shall grant compulsory licensing (e.g. local manufacture and generic version of patented products) to promote competition and access to drugs when the health of the public is at stake.

7.3.6 Regarding the exploitation of the rights conferred by patency on pharmaceuticals, the government shall design laws that prescribes a limited period immediately preceding the expiry of the patent for its agency or a third party to conduct tests on the product required for regulatory approval in the country.

7.3.7 The limited period in section 7.3.6 should also allow the agency or third party to manufacture and store the product, so that when the patent expires, a generic product can enter the market immediately.